Case 19.4

You diagnose her with essential fatty acid deficiency based on lab results showing normal zinc, vitamin A, vitamin C, carnitine levels but an elevated triene:tetraene ratio.  You increase the lipid calories to ensure that at least 10% of total calories are coming from polyunsaturated fats, and 2-4% from linoleic acid.  Her scaly skin improves.

Six months later, as a result of these complications, the patient decides she is ready to start the teduglutide in an attempt to reduce her dependence on parenteral nutrition, however she wants to know more about the side effects of this medication.

 

What are potential concerning side effects of teduglutide? Choose all that apply.
Low serum level of other prescription drugs
Tedaglutide can cause complications from increased absorption of medications with a narrow therapeutic index
Increased neoplastic growth in the gastrointestinal tract
Bowel obstructions
Intravascular Volume Depletion
Tedaglutide can cause volume overload leading to congestive heart failure exacerbations
Pancreatitis

She undergoes colonoscopy to identify and remove any colon polyps prior to initiating teduglutide.  With the initiation of teduglutide, she is able to reduce the number of days she requires TPN to 4 days per week, and lipids to 2 days per week, however two years later, her liver enzymes still have not normalized, and you are concerned her liver disease has progressed.  You perform a liver biopsy, which shows signs of cholestasis and bridging fibrosis, consistent with PNALD.  Imaging demonstrates an enlarged portal vein and spleen concerning for portal hypertension.  You discuss with her that she might be a candidate for intestinal transplant in combination with liver transplant.

Which of the following is NOT an indication for intestinal transplant in patients with short bowel?
Recurrent severe sepsis from central line infections
Loss of access to two or more central veins
Inability to tolerate oral intake
Liver failure as a result of complications from short bowel syndrome and parenteral nutrition associated liver disease
High morbidity or inability to function related to intestinal failure